Article citationsMore>>

Falzon, D., Mirzayev, F., Wares, F., Baena, I. G., Zignol, M., Linh, N., Raviglione, M., et al. (2015) Multidrug-Resistant Tuberculosis around the World: What Progress Has Been Made? The European Respiratory Journal, 45, 150-160.
https://doi.org/10.1183/09031936.00101814

has been cited by the following article:

• TITLE: Low Detection Rate of Multidrug-Resistant and Rifampicin-Resistant Tuberculosis in the Democratic Republic of Congo: Trend Analysis 2013-2017

  AUTHORS: Innocent Kashongwe Murhula, Fina Mawete, Lay Ofali, Michel Kaswa, Francois Lepira Bompeka, Jean Marie Kayembe Ntumba, Zacharie Kashongwe Munogolo

  KEYWORDS: MDR-RR TB, Trends Screening, DRC

  JOURNAL NAME: Journal of Tuberculosis Research, Vol.7 No.4, November 8, 2019

  ABSTRACT: The Democratic Republic of Congo is one of the countries with a high preva-lence of multidrug-resistant tuberculosis (MDR-TB) in Africa and worldwide. This study aims to describe the trends and level of screening since 2013. This is a retrospective descriptive study based on quarterly reports from the provinces. The number of cases, past histories, age, sex and HIV Co-infection was identi-fied. It emerges that the number of cases increases significantly but does not reach the forecasts yet (912 cases of MDR/RR and XDR diagnosed in 2017 out of 3948 cases expected with a gap of 77%). Patients with a history of TB pre-dominate (63.5% in 2017); but the proportion of patients with no history of TB increases (36.5% in 2017). This suggests high rates among contacts. Women (37.8%) and children under 15 (2.7%) are less represented. TB/HIV Co-infection is 12% as for sensitive cases. Efforts still need to be made to improve screening.